Identification of a Proliferator-Activated Receptor-Γ Antagonist for the Treatment of Type 2 Diabetes Mellitus

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2014.2096
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

In Silico Identification of Novel Glucagon Receptor Antagonist for the Treatment of Type 2 Diabetes Mellitus

Enzyme Engineering
2015English

A Synthetic Antagonist for the Peroxisome Proliferator-Activated Receptor Γ Inhibits Adipocyte Differentiation

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2000English

Peroxisome Proliferator-Activated Receptor Γ-Mediated Differentiation

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

Peroxisome Proliferator-Activated Receptor-Γ (PPARG; PPARγ)

Science-Business eXchange
2009English

Mutation Analysis of Peroxisome Proliferator-Activated Receptor-Γ Coactivator-1 (PGC-1) and Relationships of Identified Amino Acid Polymorphisms to Type II Diabetes Mellitus

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2001English

Peroxisome Proliferator-Activated Receptor Gene Variation Influences Age of Onset and Progression of Type 2 Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2005English

Peroxisome Proliferator-Activated Receptor Γ 2 Modulates Late-Pregnancy Homeostatic Metabolic Adaptations

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2016English

Insulinization: A Promising Strategy for the Treatment of Type 2 Diabetes Mellitus

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2013English

Combination of Peroxisome Proliferator-Activated Receptor Α/Γ Agonists May Benefit Type 2 Diabetes Patients With Coronary Artery Disease Through Inhibition of Inflammatory Cytokine Secretion

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy